Tacrine–Hydrogen Sulfide Donor Hybrid Ameliorates Cognitive Impairment in the Aluminum Chloride Mouse Model of Alzheimer’s Disease-Reference-Cited by-同舟云学术

Tacrine–Hydrogen Sulfide Donor Hybrid Ameliorates Cognitive Impairment in the Aluminum Chloride Mouse Model of Alzheimer’s Disease

Published:2019-06-03 Issue:8 Volume:10 Page:3500-3509
ISSN:1948-7193
Container-title:ACS Chemical Neuroscience
language:en
Short-container-title:ACS Chem. Neurosci.

Author:

Cheng Xiao-jing¹,Gu Jing-xue¹,Pang Yi-peng¹,Liu Jiao¹,Xu Ting¹,Li Xin-rui¹,Hua Yu-zhou¹,Newell Kelly A.²,Huang Xu-Feng³²,Yu Yinghua³²,Liu Yi¹^ORCID

Affiliation:

1. Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou, Jiangsu 221004, China

2. Illawarra Health and Medical Research Institute and Faculty of Science, Medicine and Health, University of Wollongong, Wollongong, NSW 2522, Australia

3. Jiangsu Key Laboratory of Immunity and Metabolism, Department of Pathogen Biology and Immunology, Xuzhou Medical University, Xuzhou, Jiangsu 221004, China

Funder

National Natural Science Foundation of China

Open Research Project of Jiangsu Key Laboratory of Immunity and Metabolism

Publisher

American Chemical Society (ACS)

Subject

Cell Biology,Cognitive Neuroscience,Physiology,Biochemistry,General Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.9b00120

Reference49 articles.

1. The Emerging Role of Innate Immunity in Alzheimer’s Disease

2. Syntheses of coumarin–tacrine hybrids as dual-site acetylcholinesterase inhibitors and their activity against butylcholinesterase, Aβ aggregation, and β-secretase